WeVote
Log In

Bill

CN

Bill

SB 211

Revise emergency use of epinephrine in school setting to include nasal spray

2025 Regular Session Introduced by Cora Neumann

Montana law now permits schools to use epinephrine nasal spray alongside auto-injectors for treating severe allergic reactions in students.

Chapter Number Assigned
#healthcareservices(seealso:health) #schoolsandeducation
0
WeVote Research Nonpartisan
Bill Summary · SB 211

Legislative bill overview

SB 211 expands Montana schools' emergency epinephrine options by authorizing the use of nasal spray formulations in addition to traditional auto-injectors (like EpiPens). The bill allows trained school personnel to administer epinephrine nasal spray to students experiencing severe allergic reactions during school hours.

Why is this important

Epinephrine nasal spray offers a potentially faster, easier-to-administer alternative that may reduce barriers to treatment during life-threatening anaphylaxis events. This expansion could improve response times and reduce hesitation among untrained staff who may be uncomfortable using auto-injectors, ultimately saving lives in critical moments.

Potential points of contention

  • Training and competency requirements — The bill may create ambiguity about what level of training is necessary for nasal spray administration versus auto-injectors, potentially creating liability concerns for schools
  • Cost and access disparities — Nasal spray formulations may have different pricing than auto-injectors, raising questions about whether all schools can afford adequate supplies
  • Medical protocol clarity — Questions remain about whether nasal spray is equally effective in all anaphylaxis scenarios and whether schools need updated emergency response protocols to accommodate this new delivery method

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.